Some detailed articles on specific MPN treatments are outlined below.

CYTOREDUCTION: articles discussing when to start, and evidence on Hydroxycarbamide (hydroxyurea) versus Interferon Alpha (pegasys).  


Ropeginterferon  – a pegylated form of interferon alpha approved in Europe for PV but not yet available in Australia.

Possible future treatments via targeted therapies – not yet available in Australia

Share to: